Laurion Capital Management LP Organogenesis Holdings Inc. Transaction History

Laurion Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.89 - $2.93 $30,472 - $47,240	16,123 New	16,123 $34,000
Q2 2022 Aug 15, 2022	SELL	$4.74 - $8.15 $1.2 Million - $2.06 Million	-252,338 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$6.47 - $9.57 $1.63 Million - $2.41 Million	252,338 New	252,338 $1.92 Million
Q2 2021 Aug 13, 2021	SELL	$14.92 - $23.23 $1.64 Million - $2.56 Million	-110,141 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$7.33 - $21.06 $3.32 Million - $9.54 Million	-452,839 Reduced 80.44%	110,141 $2.01 Million
Q4 2020 Feb 12, 2021	BUY	$3.63 - $7.53 $2.04 Million - $4.24 Million	562,980 New	562,980 $4.24 Million
Q1 2020 May 14, 2020	SELL	$2.92 - $5.31 $73,000 - $132,750	-25,000 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$4.7 - $8.11 $117,500 - $202,750	25,000 New	25,000 $120,000

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $406M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.